News
Media
Peer ExchangeCase-Based Psych PerspectivesClinical Case CollectiveClinical Forum InsightsInsightsPeers & PerspectivesSlideshowsVideos
Conferences
Conference CoverageConference Listing
Publication
Psychiatric Times
More
Job Board
CME/CE
Partners
Editorial
Resources
Between the LinesExpert PerspectivesClinical ConsultClinical ScalesInteractive ToolsLive EventsPartner PerspectivesQ&AQuizzesSeriesSpecial ReportsSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Publication
  • Job Board
  • CME/CE
  • Partners
  • Editorial
  • Resources
  • Subscribe
  • ADHD
  • Addiction & Substance Use
    • Gambling
    • Opioid Related Disorders
    • Alcohol Abuse
    • Amphetamine Related Disorders
    • Substance Use Disorder
  • Alzheimer Disease
  • Anxiety & Stress Disorders
    • Disaster Psychiatry
    • Panic Disorder
    • Trauma And Violence
    • Traumatic Stress Disorders
  • Bipolar Disorder
    • Mania
  • COVID-19
  • Cannabis
  • Case Discussions
  • Child & Adolescent Psychiatry
  • Climate Change
  • Comorbidity
  • Compulsive Disorders
  • Cultural Psychiatry
  • Digital Therapeutics
  • Diversity, Equity, Inclusion
  • Drug Watch
  • Eating Disorders
  • Emergency Psychiatry
  • Ethics
  • Forensic Psychiatry
    • Munchausen Syndrome
    • Sexual Offenses
  • Geriatric Psychiatry
  • Integrative Psychiatry
  • Major Depressive Disorder
  • Media & Psychiatry
  • Mental Health Awareness Month
  • Mood Disorders
  • Neuropsychiatry
    • Cognitive Disorders
    • Dementia
    • Autism
  • PTSD
  • Personality Disorders
    • Compulsive Personality Disorder
    • Dependent Personality Disorder
    • Dissociative Identity Disorder
    • Histrionic Personality Disorder
    • Schizoid Personality Disorder
    • Antisocial Personality Disorder
    • Borderline Personality
  • Postpartum Depression
  • Psychedelics
  • Psychopharmacology
  • Psychosomatics
    • Delirium
    • Metabolic Disorders
    • Somatoform Disorder
  • Psychotherapy
    • Cognitive Behavioral Therapy
  • Schizophrenia/Psychosis
    • Paranoid Schizophrenia
    • Psychotic Affective Disorders
    • Schizoaffective
    • Schizophrenia Psychotic Features
    • Schizotypal Personality Disorder
    • Catatonic Schizophrenia
  • Sleep Disorders
    • Narcolepsy
    • Nocturnal Paroxysmal Dystonia
    • Sleep Deprivation
    • Sleep Wake Transition
    • Circadian Rhythm Sleep Disorders
  • Special Populations
    • Pervasive Developmental Disorder
    • LGBTQ+
    • Gender Issues
    • Military Mental Health
  • Sports Psychiatry
  • Suicide
  • Tardive Dyskinesia
  • Technology & Psychiatry
    • Artificial Intelligence
  • Transcranial Magnetic Stimulation
Spotlight -
Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|
Major Depressive Disorder
Advertisement

Michael J. Peterson, MD, PhD

Advertisement

Articles by Michael J. Peterson, MD, PhD

Bioethical Challenges for Psychiatrists: Determination of Decisional Capacity

ByCynthia M.A. Geppert, MD, PhD, MA, MPH, MSBE, DPS, MSJ,Mary Ann Cohen, MD,James A. Bourgeois, OD, MD,Michael J. Peterson, MD, PhD,Academy of Psychosomatic Medicine
July 26th 2016

The authors parse myths and facts about decisional capacity, with the goal of preserving patients' dignity and autonomy and helping you mediate conflicts, meet bioethical challenges, and provide compassionate resolutions.

Advertisement

Latest Updated Articles

  • Bioethical Challenges for Psychiatrists: Determination of Decisional Capacity
    Bioethical Challenges for Psychiatrists: Determination of Decisional Capacity

    Published: July 26th 2016 | Updated:



Advertisement
Advertisement

Trending on Psychiatric Times

1

New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia

2

Accident, or Is It? The Watershed Area Between Trauma and Suicide

3

FDA Accepts Investigational New Drug Application for COMP360 for PTSD

4

The Bind of the Binary: Psychiatry’s Critics and the Law of the Excluded Middle

5

FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1

  • About
  • Advertise
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us